Houston biotech co. developing ALS therapies launches with $10M in funding
Coya Therapeutics is using regulatory T-cells therapy in clinical trials to slow the progression of ALS in patients.
Read More
Building "Bridges" Across the Bayou City!
Coya Therapeutics is using regulatory T-cells therapy in clinical trials to slow the progression of ALS in patients.
Read More